A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Laekna Limited
NuCana plc
OncoC4, Inc.
Incyte Corporation
National Cancer Institute (NCI)
University of Miami
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)